Shares of Fresenius Medical Care AG (NYSE:FMS - Get Free Report) gapped down before the market opened on Friday . The stock had previously closed at $22.48, but opened at $21.85. Fresenius Medical Care shares last traded at $21.91, with a volume of 23,815 shares traded.
Analysts Set New Price Targets
A number of equities research analysts recently weighed in on FMS shares. Berenberg Bank began coverage on Fresenius Medical Care in a report on Wednesday, November 6th. They issued a "buy" rating and a $25.60 price target on the stock. StockNews.com initiated coverage on Fresenius Medical Care in a research note on Thursday. They set a "strong-buy" rating for the company. Finally, Truist Financial lifted their target price on Fresenius Medical Care from $22.00 to $23.00 and gave the company a "hold" rating in a research note on Monday, October 7th.
Read Our Latest Report on Fresenius Medical Care
Fresenius Medical Care Stock Performance
The company has a debt-to-equity ratio of 0.42, a current ratio of 1.37 and a quick ratio of 1.02. The firm has a market cap of $12.92 billion, a P/E ratio of 18.20, a PEG ratio of 1.03 and a beta of 0.91. The stock's 50 day moving average is $20.97 and its two-hundred day moving average is $20.31.
Institutional Investors Weigh In On Fresenius Medical Care
Large investors have recently made changes to their positions in the stock. Franklin Resources Inc. boosted its holdings in shares of Fresenius Medical Care by 3.3% during the 3rd quarter. Franklin Resources Inc. now owns 74,640 shares of the company's stock worth $1,490,000 after buying an additional 2,386 shares during the period. Wilmington Savings Fund Society FSB bought a new stake in shares of Fresenius Medical Care in the 3rd quarter valued at $38,000. MML Investors Services LLC boosted its stake in Fresenius Medical Care by 5.3% during the third quarter. MML Investors Services LLC now owns 15,019 shares of the company's stock worth $320,000 after acquiring an additional 753 shares in the last quarter. XTX Topco Ltd lifted its stake in shares of Fresenius Medical Care by 70.8% in the third quarter. XTX Topco Ltd now owns 39,769 shares of the company's stock valued at $847,000 after buying an additional 16,487 shares in the last quarter. Finally, National Bank of Canada FI lifted its stake in shares of Fresenius Medical Care by 17.4% in the third quarter. National Bank of Canada FI now owns 23,270 shares of the company's stock valued at $496,000 after buying an additional 3,451 shares in the last quarter. Institutional investors own 8.25% of the company's stock.
Fresenius Medical Care Company Profile
(
Get Free Report)
Fresenius Medical Care AG provides dialysis and related services for individuals with renal diseases in Germany, North America, and internationally. The company offers dialysis treatment and related laboratory and diagnostic services through a network of outpatient dialysis clinics; materials, training, and patient support services comprising clinical monitoring, follow-up assistance, and arranging for delivery of the supplies to the patient's residence; and dialysis services under contract to hospitals in the United States for the hospitalized end-stage renal disease (ESRD) patients and for patients suffering from acute kidney failure.
Further Reading
Before you consider Fresenius Medical Care, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Fresenius Medical Care wasn't on the list.
While Fresenius Medical Care currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to avoid the hassle of mudslinging, volatility, and uncertainty? You'd need to be out of the market, which isn’t viable. So where should investors put their money? Find out with this report.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
